Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Regulatory T Cells Control PF4/Heparin Antibody Production in Mice

Yongwei Zheng, Wen Zhu, Dipica Haribhai, PhD, Calvin B. Williams, PhD, Richard H. Aster, MD, Renren Wen, PhD, Demin Wang, PhD

Blood (2018) 132 (Supplement 1): 2542.

https://doi.org/10.1182/blood-2018-99-113049

Published: 2018

Journal Articles

Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression

Ludovic Belle, Kimberle Agle, Vivian Zhou, Cheng Yin-Yuan, Richard Komorowski, Daniel Eastwood, Brent Logan, Jie Sun, Nico Ghilardi, Daniel Cua, Calvin B. Williams, Melanie Gaignage, Reece Marillier, Jacques van Snick, William R. Drobyski

Blood (2016) 128 (16): 2068–2082.

https://doi.org/10.1182/blood-2016-02-698241

Published: 2016

Journal Articles

TTT-3002 Is Active Against Relapsed/Refractory AML Patient Bone Marrow With FLT3 TKI-Resistance Mutations At Residue D835

Hayley S Ma, Ph.D., Bao Nguyen, M.S., Mark Levis, MD, PhD, Allen B Williams, PhD, Donald Small, MD, PhD

Blood (2013) 122 (21): 3818.

https://doi.org/10.1182/blood.V122.21.3818.3818

Published: 2013

Journal Articles

Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia

Allen B. Williams, Li Li, Bao Nguyen, Patrick Brown, Mark Levis, Donald Small

Blood (2012) 120 (15): 3069–3079.

https://doi.org/10.1182/blood-2012-01-403493

Published: 2012

Journal Articles

Results of a Phase I Open-Label Study of Decitabine in Combination with Midostaurin (PKC412) for Elderly (Age ≥ 60) Newly Diagnosed or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia,

Casey B Williams, Pharm.D., Suman Kambhampati, MD, Siddhartha Ganguly, MD, Omar S. Aljitawi, MD, Ruben Reyes, MD, Allan Fleming, MD, Kapil N. Bhalla, MD, Sunil Abhyankar, MD, Joseph McGuirk, DO

Blood (2011) 118 (21): 3610.

https://doi.org/10.1182/blood.V118.21.3610.3610

Published: 2011

Journal Articles

Targeting Mutant Nucleophosmin 1 (NPM1) Induces Differentiation, Loss of Survival and Sensitizes AML Cells to All-Trans Retinoic Acid, Cytarbine and FLT3 Antagonists

Ramesh Balusu, PhD, Josiah Cox, Stacey Hembruff, MS, Warren Fiskus, BSc, PhD, Rekha Rao, PhD, Uma Mudunuru, MS, Ruben Reyes, MD, Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Heather Male, MD, Allan Fleming, MD, Casey B Williams, Pharm.D., Joseph McGuirk, DO, Kapil N. Bhalla, MD

Blood (2011) 118 (21): 733.

https://doi.org/10.1182/blood.V118.21.733.733

Published: 2011

Journal Articles

Six Year, Single Institution, off-Label Use of Recombinant Factor VIIa

Mayur B. Patel, MD, Syamal D. Bhattacharya, MD, Judson B. Williams, MD, Timothy E. Sweeney, PhD, Steven N. Vaslef, MD, PhD, G. Chad Hughes, MD, Paul C. Kuo, Jeffery H. Lawson, MD, PhD

Blood (2010) 116 (21): 1402.

https://doi.org/10.1182/blood.V116.21.1402.1402

Published: 2010

Journal Articles

Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5

Ryan D. Schulteis, Haiyan Chu, Xuezhi Dai, Yuhong Chen, Brandon Edwards, Dipica Haribhai, Calvin B. Williams, Subramaniam Malarkannan, Martin J. Hessner, Sanja Glisic-Milosavljevic, Srikanta Jana, Edward J. Kerschen, Soumitra Ghosh, Demin Wang, Anne E. Kwitek, Ake Lernmark, Jack Gorski, Hartmut Weiler

Blood (2008) 112 (13): 4905–4914.

https://doi.org/10.1182/blood-2008-03-146555

Published: 2008

Includes: Supplemental data

Journal Articles

Nitric Oxide-Dependent Blood Flow in Patients with Sickle Cell Disease Is Reflected by the Reactive Hyperemia-Peripheral Arterial Tonometry Index

Megan L. Krajewski, BS, James A. Kim, BM, Laurel G. Mendelsohn, BS, Candice B. Williams, MD, Mark T. Gladwin, MD, Gregory J. Kato, MD

Blood (2008) 112 (11): 2486.

https://doi.org/10.1182/blood.V112.11.2486.2486

Published: 2008

Journal Articles

Impaired Maturation and Survival of T Lymphocytes, B Lymphocytes, and NK Cells in Mice Lacking Gimap5/Ian5.

Ryan D. Schulteis, Xuezhi Dai, Haiyan Chu, PhD, Brandon Edwards, Dipica Haribhai, Calvin B. Williams, MD, PhD, Subramanium Malarkannan, PhD, Hessner J. Martin, PhD, Kwitek E. Anne, PhD, Åke Lernmark, MD, Jack Gorski, PhD, Demin Wang, PhD, Hartmut Weiler, PhD

Blood (2006) 108 (11): 921.

https://doi.org/10.1182/blood.V108.11.921.921

Published: 2006

Journal Articles

Inhibition of Mutant FLT3 Activation by the Novel Tyrphostin, AGS324.

Allen B. Williams, PhD, Aviv Gazit, PhD, Bao Nguyen, MS, Shimon Slavin, MD, Don Small, MD, PhD

Blood (2005) 106 (11): 3371.

https://doi.org/10.1182/blood.V106.11.3371.3371

Published: 2005

Journal Articles

LFA-1 is required for retention of effector CD8 T cells in mouse lungs

Jayant Thatte, Vrushali Dabak, Mark B. Williams, Thomas J. Braciale, Klaus Ley

Blood (2003) 101 (12): 4916–4922.

https://doi.org/10.1182/blood-2002-10-3159

Published: 2003

Journal Articles

Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants

S Chin, B Williams, P Gottlieb, H Margolis-Nunno, E Ben-Hur, J Hamman, R Jin, E Dubovi, B Horowitz

Blood (1995) 86 (11): 4331–4336.

https://doi.org/10.1182/blood.V86.11.4331.bloodjournal86114331

Published: 1995

Journal Articles

Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse

SK Nilsson, GJ Lieschke, CC Garcia-Wijnen, B Williams, D Tzelepis, G Hodgson, D Grail, AR Dunn, I Bertoncello

Blood (1995) 86 (1): 66–72.

https://doi.org/10.1182/blood.V86.1.66.bloodjournal86166

Published: 1995

Journal Articles

The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis [see comments]

WI Bensinger, TH Price, DC Dale, FR Appelbaum, R Clift, K Lilleby, B Williams, R Storb, ED Thomas, CD Buckner

Blood (1993) 81 (7): 1883–1888.

https://doi.org/10.1182/blood.V81.7.1883.1883

Published: 1993

NARROW

Regulatory T Cells Control PF4/Heparin Antibody Production in Mice

Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression

TTT-3002 Is Active Against Relapsed/Refractory AML Patient Bone Marrow With FLT3 TKI-Resistance Mutations At Residue D835

Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia

Results of a Phase I Open-Label Study of Decitabine in Combination with Midostaurin (PKC412) for Elderly (Age ≥ 60) Newly Diagnosed or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia,

Targeting Mutant Nucleophosmin 1 (NPM1) Induces Differentiation, Loss of Survival and Sensitizes AML Cells to All-Trans Retinoic Acid, Cytarbine and FLT3 Antagonists

Six Year, Single Institution, off-Label Use of Recombinant Factor VIIa

Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5

Nitric Oxide-Dependent Blood Flow in Patients with Sickle Cell Disease Is Reflected by the Reactive Hyperemia-Peripheral Arterial Tonometry Index

Impaired Maturation and Survival of T Lymphocytes, B Lymphocytes, and NK Cells in Mice Lacking Gimap5/Ian5.

Inhibition of Mutant FLT3 Activation by the Novel Tyrphostin, AGS324.

LFA-1 is required for retention of effector CD8 T cells in mouse lungs

Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants

Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse

The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis [see comments]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only